Puheterapia Leksikko Oy is a limited company based in Nurmijärvi, registered in 2020. In the financial year ending 31.12.2025, revenue was 105 t€ and operating profit 15 t€; equity ratio 90.9 %. Its taxable income in 2024 was 7 813 € and its income taxes 1 563 €.
Nurmijärvi: 15 new companies in 30 days
- Lumentec OyOhjelmistojen suunnittelu ja valmistus
- Nurmijärven Onnenkimpale ryMuualla luokittelematon muu monenlainen sosiaalihuollon avopalvelutoiminta
- Tanmore OyRakennuttaminen ja rakennushankkeiden kehittäminen
Financials
| Key figures | 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 |
|---|---|---|---|---|
| Revenue | 105 t€ | 102 t€ | 71 t€ | 44 t€ |
| Revenue change | 2,9 % | 43,0 % | 62,5 % | – |
| EBITDA | 15 t€ | 7 723 € | 3 769 € | 4 752 € |
| EBITDA % | 14,0 % | 7,6 % | 5,3 % | 10,8 % |
| Operating profit | 15 t€ | 7 723 € | 3 769 € | 4 752 € |
| Operating margin | 14,0 % | 7,6 % | 5,3 % | 10,8 % |
| Net profit | 13 t€ | 6 163 € | 3 014 € | 3 716 € |
| Personnel costs | -55 t€ | 55 t€ | 58 t€ | 30 t€ |
| Equity ratio | 90,9 % | 66,1 % | 54,9 % | 63,1 % |
| Quick ratio | 10,94 | 2,95 | 2,22 | 2,71 |
| Current ratio | 10,94 | 2,95 | 2,22 | 2,71 |
| Debt to revenue | 2,4 % | 6,4 % | 8,2 % | 5,5 % |
| Return on equity | 52,6 % | 48,3 % | 42,1 % | 89,7 % |
| Balance sheet total | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Equity | 25 t€ | 13 t€ | 7 159 € | 4 145 € |
| Cash and bank | 22 t€ | 7 909 € | 8 852 € | 1 594 € |
Balance sheet
Income statement and balance sheet
Income statement
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 105 t€ | 102 t€ | 71 t€ | 44 t€ |
| Raw materials and services | 14 € | -53 € | -98 € | -423 € |
| Personnel expenses | 55 t€ | -55 t€ | -58 t€ | -30 t€ |
| Other operating expenses | 35 t€ | -39 t€ | -10 t€ | -8 474 € |
| Operating profit (loss) | 15 t€ | 7 723 € | 3 769 € | 4 752 € |
| Financial income and expenses + (-) | -1 244 € | 3 € | -1 € | 0 € |
| Profit (loss) before appropriations and taxes | 16 t€ | 7 726 € | 3 768 € | 4 752 € |
| Income taxes | 2 949 € | -1 563 € | -754 € | -1 036 € |
| Profit (loss) for the financial year | 13 t€ | 6 163 € | 3 014 € | 3 716 € |
Balance sheet
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Receivables | 5 591 € | 11 t€ | 4 187 € | 4 976 € |
| Cash in hand and at banks | 22 t€ | 7 909 € | 8 852 € | 1 594 € |
| Current assets | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Assets | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Capital and reserves | 25 t€ | 13 t€ | 7 159 € | 4 145 € |
| Short-term liabilities | 2 490 € | 6 550 € | 5 880 € | 2 425 € |
| Liabilities | 2 490 € | 6 550 € | 5 880 € | 2 425 € |
All financial statement items (33)
| 31.12.2025 | 31.12.2024 | 31.12.2023 | 31.12.2022 | |
|---|---|---|---|---|
| Turnover | 105 t€ | 102 t€ | 71 t€ | 44 t€ |
| Raw materials and services | 14 € | -53 € | -98 € | -423 € |
| Personnel expenses | 55 t€ | -55 t€ | -58 t€ | -30 t€ |
| Other operating expenses | 35 t€ | -39 t€ | -10 t€ | -8 474 € |
| Operating profit (loss) | 15 t€ | 7 723 € | 3 769 € | 4 752 € |
| Financial income and expenses + (-) | -1 244 € | 3 € | -1 € | 0 € |
| Profit (loss) before appropriations and taxes | 16 t€ | 7 726 € | 3 768 € | 4 752 € |
| Income taxes | 2 949 € | -1 563 € | -754 € | -1 036 € |
| Profit (loss) for the financial year | 13 t€ | 6 163 € | 3 014 € | 3 716 € |
| Receivables | 5 591 € | 11 t€ | 4 187 € | 4 976 € |
| Cash in hand and at banks | 22 t€ | 7 909 € | 8 852 € | 1 594 € |
| Current assets | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Assets | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Capital and reserves | 25 t€ | 13 t€ | 7 159 € | 4 145 € |
| Short-term liabilities | 2 490 € | 6 550 € | 5 880 € | 2 425 € |
| Liabilities | 2 490 € | 6 550 € | 5 880 € | 2 425 € |
| Income from shares in participating interests | 1 248 € | 0 € | – | – |
| Profit (loss) for the period, equity | 13 t€ | 6 163 € | 3 014 € | 3 716 € |
| Pension expenses | – | – | 0 € | -3 632 € |
| Short-term accounts payable | – | 0 € | 6 € | 55 € |
| Liabilities | 27 t€ | 19 t€ | 13 t€ | 6 570 € |
| Other interest and financial income from non-group companies | 0 € | 3 € | 1 € | 0 € |
| Short-term accrued expenses and deferred income | 1 549 € | 3 988 € | 2 275 € | 950 € |
| Short-term sales receivables | 5 591 € | 11 t€ | 3 941 € | 4 976 € |
| Interest expenses and other financial expenses for non-Group companies | 4 € | 0 € | -1 € | 0 € |
| Other current liabilities | 940 € | 2 562 € | 3 599 € | 1 420 € |
| Short-term receivables | 5 591 € | 11 t€ | 4 187 € | 4 976 € |
| Other short-term receivables | – | 0 € | 246 € | 0 € |
| Retained earnings | 12 t€ | 6 586 € | 4 145 € | 429 € |
| Services purchased | – | – | 0 € | -6 € |
| Purchases during the financial year | 14 € | -53 € | -98 € | -417 € |
| Other social security expenses | 1 014 € | -666 € | -855 € | -371 € |
| Wages and salaries | 54 t€ | -55 t€ | -57 t€ | -26 t€ |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Puheterapia Leksikko Oy is in the lower half of the industry class other human health activities n.e.c. (1445 companies with taxable income; median 18 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.